Veracyte (VCYT) Receivables - Net (2016 - 2025)
Historic Receivables - Net for Veracyte (VCYT) over the last 14 years, with Q3 2025 value amounting to $47.8 million.
- Veracyte's Receivables - Net fell 201.0% to $47.8 million in Q3 2025 from the same period last year, while for Sep 2025 it was $47.8 million, marking a year-over-year decrease of 201.0%. This contributed to the annual value of $46.5 million for FY2024, which is 1522.36% up from last year.
- Per Veracyte's latest filing, its Receivables - Net stood at $47.8 million for Q3 2025, which was down 201.0% from $50.8 million recorded in Q2 2025.
- In the past 5 years, Veracyte's Receivables - Net registered a high of $53.8 million during Q1 2025, and its lowest value of $27.9 million during Q1 2021.
- In the last 5 years, Veracyte's Receivables - Net had a median value of $42.5 million in 2022 and averaged $43.2 million.
- Its Receivables - Net has fluctuated over the past 5 years, first surged by 12865.17% in 2021, then tumbled by 827.56% in 2023.
- Over the past 5 years, Veracyte's Receivables - Net (Quarter) stood at $41.5 million in 2021, then increased by 6.17% to $44.0 million in 2022, then dropped by 8.28% to $40.4 million in 2023, then grew by 15.22% to $46.5 million in 2024, then rose by 2.8% to $47.8 million in 2025.
- Its Receivables - Net stands at $47.8 million for Q3 2025, versus $50.8 million for Q2 2025 and $53.8 million for Q1 2025.